Intelligent Robotics for Very Early Mobilization of Intensive Care Patients
Economic and demographic trends demand an increase in efficiency in the healthcare system. In times of aging population and a shortage of healthcare professionals, new therapy interventions need to be developed.
Reactive Robotics GmbH is the first company worldwide that systematically addresses the Very Early Mobilization (VEM) of patients in the Intensive Care Unit (ICU).
We develop an intelligent, adaptive robotic system to support critically ill patients and their care takers.
The Importance of VEM – Very Early Mobilization Therapy
Clinical studies demonstrate that critically ill patients in the ICU who undergo VEM therapy achieve better treatment results.
Our goal is to enable intensive care clinicians to provide ICU patients with the best possible care.
Our initial clients will be hospitals with ICUs for mechanically ventilated, neurological or trauma patients – for these patient groups, the largest body of clinical evidence is available. Later markets will include the large indications of orthopedic and cardiological patients, geriatric patients as well as elderly patients in home care who are unable to leave bed will follow.
Combining world class robotics with experienced startup leadership
Our team has a combined 11 years of rehabilitation robotics research, vast startup experience and a large clinical network to bring this device to life. We are a diverse international team of employees and students covering the professional areas of:
to bring this device to the patients.
From February 2015 through October 2016, Reactive Robotics enrolled in the ESA-BIC, the Business Incubator Center of the European Space Agency. On the investment side, we are supported by
In March 2016, we presented the first prototype of our device and in Q1/2018 we are able to deliver our first clinical testproduct.
We are proud to feature an excellent array of supporters that provide advice on every level required for the successful start-up of a medical technology company. Advisors provide access to patients, support us in engineering, on legal issues and when dealing with the details of registering a medical device with the authorities.
Since October 2016, we are located in the heart of Munich. In our spacious open office, we are developing the next generation medical technology.
Reactive Robotics is a Member of the Research Project MobIPaR (Mechatronische Entwicklung einer adaptiven Plattform zur Mobilisation Intensiv-Pflegebedürftiger), funded by the German Federal Ministry of Education and Research. For further information, please visit the MobIPaR Project Homepage.
Dr. Arash Dodge
Expert in Rehabilitation Robotics
Schoen Kliniken Group
Prof. Dr. Gerd Hirzinger
DLR (German Aerospace Agency)
Our team is the key to our success
At Reactive Robotics you can push the frontiers of medical technology and enjoy our exciting and fun team atmosphere. With us, you can work on problems that matter - your solutions will have direct impact on patients in Intensive Care Units.
Additional-benefits (everything is free for you):
Full-time employee (m/f):
Full-time employee (m/f):
Your desired position is not among our current openings? We are always on the lookout for talented individuals who would like to grow their career with us, do an internship or gain real-world experience as part of their studies. Feel free to send your application anytime to email@example.com. We are looking forward to hearing from you.
We drive innovation
September 29, 2017:Reactive Robotics has been successfully audited by the TÜV Süd and received the ISO 13485:2016 certificate: EN, DE.
September 08, 2017:Successful second investment round: 'Reactive Robotics GmbH is on track': EN, GER.
August 08, 2017:Article in the online magazine startUP date: 'Freiheit im Kopf': article
August 02, 2017:Article on homepage of Startup Valley: 'Humor behalten, auch wenn's heiß wird': article
July 21, 2017:Announcement of Alex' participation in the panel discussion at 16th European Health Congress in Munich: article
July 13, 2017:Japanese delegation visited Reactive Robotics in Munich: article.
June 29, 2017:Alex talks at Cyber Dialog about changes on the labour market created by robotics: article.
April 27, 2017:Alex meets Federal President Frank-Walter Steinmeier: article.
April 03, 2017:Kick-Off of the research project: MobIPaR - Mobilization of Intensive Care Patients: Article DE, EN.
March 29, 2017:Alex holds Keynote Speech at Start Summit 2017 in St. Gallen: article.
February 01, 2017:We welcome Brigitte Schraetzenstaller-Rauch to our team.
December, 06, 2016:Reactive Robotics amongst the 5 winners of the Science4Life Idea Phase: article.
December 01, 2016:We welcome Katie Jones to our team.
November 11, 2016:Alex gives talk on robots in medical technology at forum4industry in the Deutsches Museum Muenchen: article.
August 02, 2016:Reactive Robotics ranks 2nd in Munich Business Plan Contest Phase 3: article.
August 01, 2016:We welcome Maximilian Grosse-Dunker to our team.
Jun 06, 2016:Reactive Robotics receives Series-A Funding to develop and evaluate clinical prototype: Article DE, EN.
May 19, 2016:Reactive Robotics ranks 4th in Munich Business Plan Contest Phase 2: article.
March 19, 2016:Reactive Robotics chosen as one of the top 3 startups out of 200 at the StartSummit St. Gallen: article.
March 15, 2016:Alexander to present at the Startup World at the automation fair Automatica 2016. He will also participate in a Battle Talk with Poul Martin Moller, Chief Robotics Officer of the Sygehus Sonderjylland Hospital, on Tuesday, June 21.
March 14, 2016:Reactive Robotics amongst the 10 winners of the Munich Business Plan Contest Phase 1: article.
March 08, 2016:Reactive Robotics pitches at Idea Meets Money in Salzburg: article.
February 01, 2016:We welcome Christian Anton to our team.
January 04, 2016:We welcome Dr. Helfried Peyrl to our team.
Please feel free to contact us with any inquiry you might have.
FOR INVESTORS: Business plan, executive summary and pitch deck containing the current time plan, investment strategy, intellectual property and business case are available on request.
+49 89 54 636 278
80687 Munich, Germany